Lung cancer differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Lung cancer must be differentiated from other diseases that cause [[hemoptysis]], [[cough]], [[dyspnea]], [[wheeze]], [[chest pain]], [[dysphonia]], [[dysphagia]], unexplained weight loss, unexplained loss of appetite, and [[fatigue]] such as pneumonia, bronchitis, metastatic cancer from a non-thoracic primary site, infectious granuloma, pulmonary tuberculosis, tracheal tumors, and a thyroid mass.
Lung cancer must be differentiated from other conditions that cause [[hemoptysis]], [[cough]], [[dyspnea]], [[wheeze|wheezing]], [[chest pain]], [[dysphonia]], [[dysphagia]], unexplained [[weight loss]], unexplained [[loss of appetite]], and [[fatigue]]. These conditions include [[pneumonia]], [[bronchitis]], [[metastatic cancer]] from a non-[[Chest|thoracic]] primary site, [[infectious]] [[granuloma]], [[Tuberculosis|pulmonary tuberculosis]], [[Trachea|tracheal]] [[Tumor|tumors]], and a [[thyroid]] mass.




==Differentiating Lung Cancer from Other Diseases==
==Differentiating Lung Cancer from Other Diseases==


=== Lung cancer must be differentiated from other cavitary lung lesions. ===
=== Lung cancer must be differentiated from other cavitary lung lesions. The table below summarizes the differentiation: ===
<small>
<small>
{| class="wikitable"
{| class="wikitable"
Line 25: Line 25:
*Chronic smokers
*Chronic smokers
*Presents with a [[low-grade fever]], absence of [[leukocytosis]], systemic complaints [[weight loss]], [[fatigue]]
*Presents with a [[low-grade fever]], absence of [[leukocytosis]], systemic complaints [[weight loss]], [[fatigue]]
*Absence of factors that predispose to [[gastric content aspiration]], no response to [[antibiotics]] within 10 days  
*Absence of factors that predispose to [[gastric content aspiration]], no response to [[antibiotics]] within 10 days
*[[Hemoptysis]] is commonly associated with [[bronchogenic carcinoma]]
*[[Hemoptysis]] is commonly associated with [[bronchogenic carcinoma]]
|
|
*A coin-shaped lesion with thick wall(>15mm) is seen on CXR with less ground glass opacities<ref name="pmid8572761">{{cite journal |vauthors=Mouroux J, Padovani B, Elkaïm D, Richelme H |title=Should cavitated bronchopulmonary cancers be considered a separate entity? |journal=Ann. Thorac. Surg. |volume=61 |issue=2 |pages=530–2 |year=1996 |pmid=8572761 |doi=10.1016/0003-4975(95)00973-6 |url=}}</ref> <ref name="pmid16183941">{{cite journal |vauthors=Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM |title=Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome |journal=Radiology |volume=237 |issue=1 |pages=342–7 |year=2005 |pmid=16183941 |doi=10.1148/radiol.2371041650 |url=}}</ref>
*A coin-shaped lesion with thick wall(>15mm) is seen on CXR with less ground glass opacities<ref name="pmid8572761">{{cite journal |vauthors=Mouroux J, Padovani B, Elkaïm D, Richelme H |title=Should cavitated bronchopulmonary cancers be considered a separate entity? |journal=Ann. Thorac. Surg. |volume=61 |issue=2 |pages=530–2 |year=1996 |pmid=8572761 |doi=10.1016/0003-4975(95)00973-6 |url=}}</ref> <ref name="pmid16183941">{{cite journal |vauthors=Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM |title=Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome |journal=Radiology |volume=237 |issue=1 |pages=342–7 |year=2005 |pmid=16183941 |doi=10.1148/radiol.2371041650 |url=}}</ref>
*[[Bronchoalveolar lavage]] [[cytology]] shows malignant cells  
*[[Bronchoalveolar lavage]] [[cytology]] shows malignant cells
|
|
*[[Biopsy]] of lung  
*[[Biopsy]] of lung
|-
|-
|
|
*Pulmonary [[Tuberculosis, pulmonary|Tuberculosis]]  
*Pulmonary [[Tuberculosis, pulmonary|Tuberculosis]]
|
|
*Mostly in endemic areas  
*Mostly in endemic areas
*Symptoms include [[productive cough]], [[night sweats]], [[fever]], and [[weight loss]]
*Symptoms include [[productive cough]], [[night sweats]], [[fever]], and [[weight loss]]
|
|
Line 46: Line 46:
*[[Necrotizing Pulmonary Infections|Necrotizing]] [[Pneumonia]]
*[[Necrotizing Pulmonary Infections|Necrotizing]] [[Pneumonia]]
|
|
*Any age group  
*Any age group
*Acute, [[fulminant]] life threating complication of prior infection  
*Acute, [[fulminant]] life threating complication of prior infection
*>100.4 °F fever, with [[Hemodynamically unstable|hemodynamic]] instability  
*>100.4 °F fever, with [[Hemodynamically unstable|hemodynamic]] instability
*Worsening [[pneumonia]]-like symptoms  
*Worsening [[pneumonia]]-like symptoms
   
   
|
|
Line 55: Line 55:
*[[Pleural effusion]] and [[empyema]] are common findings
*[[Pleural effusion]] and [[empyema]] are common findings
|
|
*[[Complete blood count|CBC]] is positive for causative organism
*[[Complete blood count|CBC]] is positive for causative organism
|-
|-
|
|
Line 85: Line 85:
|-
|-
|
|
*[[Rheumatoid nodule]]  
*[[Rheumatoid nodule]]
|
|
*Elderly females of 40-50 age group  
*Elderly females of 40-50 age group
*Manifestation of [[rheumatoid arthritis]]
*Manifestation of [[rheumatoid arthritis]]
*Presents with other systemic symptoms including symmetric [[arthritis]] of the small joints of the hands and feet with morning stiffness are common manifestations
*Presents with other systemic symptoms including symmetric [[arthritis]] of the small joints of the hands and feet with morning stiffness are common manifestations
Line 99: Line 99:
|
|
*More common in African-American females
*More common in African-American females
*Often [[asymptomatic]] except for [[Lymphadenopathy|enlarged lymph nodes]]<ref name="pmid11734441">{{cite journal |vauthors=Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R |title=Clinical characteristics of patients in a case control study of sarcoidosis |journal=Am. J. Respir. Crit. Care Med. |volume=164 |issue=10 Pt 1 |pages=1885–9 |year=2001 |pmid=11734441 |doi=10.1164/ajrccm.164.10.2104046 |url=}}</ref>  
*Often [[asymptomatic]] except for [[Lymphadenopathy|enlarged lymph nodes]]<ref name="pmid11734441">{{cite journal |vauthors=Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R |title=Clinical characteristics of patients in a case control study of sarcoidosis |journal=Am. J. Respir. Crit. Care Med. |volume=164 |issue=10 Pt 1 |pages=1885–9 |year=2001 |pmid=11734441 |doi=10.1164/ajrccm.164.10.2104046 |url=}}</ref>
*Associated with [[restrictive lung disease]]
*Associated with [[restrictive lung disease]]
*[[Erythema nodosum]]
*[[Erythema nodosum]]
*[[Lupus pernio]] (skin lesions on face resembling lupus)
*[[Lupus pernio]] (skin lesions on face resembling lupus)
*[[Bell's palsy|Bell palsy]]
*[[Bell's palsy|Bell palsy]]
*[[Epithelioid]] [[granuloma]]<nowiki/>s containing microscopic [[Schaumann bodies|Schaumann]] and asteroid bodies  
*[[Epithelioid]] [[granuloma]]<nowiki/>s containing microscopic [[Schaumann bodies|Schaumann]] and asteroid bodies
|  
|  
*On CXR bilateral [[Lymphadenopathy|adenopathy]] and coarse reticular opacities are seen  
*On CXR bilateral [[Lymphadenopathy|adenopathy]] and coarse reticular opacities are seen
*CT of the chest demonstrates extensive [[Hilar lymphadenopathy|hilar]] and mediastinal adenopathy
*CT of the chest demonstrates extensive [[Hilar lymphadenopathy|hilar]] and mediastinal adenopathy
*Additional findings on CT include [[fibrosis]] (honeycomb, linear, or associated with bronchial distortion), pleural thickening, and ground-glass opacities.<ref name="pmid2748828">{{cite journal |vauthors=Brauner MW, Grenier P, Mompoint D, Lenoir S, de Crémoux H |title=Pulmonary sarcoidosis: evaluation with high-resolution CT |journal=Radiology |volume=172 |issue=2 |pages=467–71 |year=1989 |pmid=2748828 |doi=10.1148/radiology.172.2.2748828 |url=}}</ref>
*Additional findings on CT include [[fibrosis]] (honeycomb, linear, or associated with bronchial distortion), pleural thickening, and ground-glass opacities.<ref name="pmid2748828">{{cite journal |vauthors=Brauner MW, Grenier P, Mompoint D, Lenoir S, de Crémoux H |title=Pulmonary sarcoidosis: evaluation with high-resolution CT |journal=Radiology |volume=172 |issue=2 |pages=467–71 |year=1989 |pmid=2748828 |doi=10.1148/radiology.172.2.2748828 |url=}}</ref>
Line 128: Line 128:
*[[Langerhans cell histiocytosis|Langerhans]] cell [[Langerhans cell histiocytosis|Histiocytosis]]<ref name="pmid22429393">{{cite journal |vauthors=Suri HS, Yi ES, Nowakowski GS, Vassallo R |title=Pulmonary langerhans cell histiocytosis |journal=Orphanet J Rare Dis |volume=7 |issue= |pages=16 |year=2012 |pmid=22429393 |pmc=3342091 |doi=10.1186/1750-1172-7-16 |url=}}</ref>
*[[Langerhans cell histiocytosis|Langerhans]] cell [[Langerhans cell histiocytosis|Histiocytosis]]<ref name="pmid22429393">{{cite journal |vauthors=Suri HS, Yi ES, Nowakowski GS, Vassallo R |title=Pulmonary langerhans cell histiocytosis |journal=Orphanet J Rare Dis |volume=7 |issue= |pages=16 |year=2012 |pmid=22429393 |pmc=3342091 |doi=10.1186/1750-1172-7-16 |url=}}</ref>
|
|
*Exclusively afflicts smokers, with a peak age of onset of between 20 and 40 years  
*Exclusively afflicts smokers, with a peak age of onset of between 20 and 40 years
*Clinical presentation varies, but symptoms generally include months of dry [[cough]], [[fever]], [[night sweats]], and [[weight loss]]
*Clinical presentation varies, but symptoms generally include months of dry [[cough]], [[fever]], [[night sweats]], and [[weight loss]]
*Skin is involved in 80% of the cases, scaly [[erythematous rash]] is typical  
*Skin is involved in 80% of the cases, scaly [[erythematous rash]] is typical
|
|
*Thin-walled cystic cavities are the usual radiographic manifestation, observed in over 50% of patients by either CXR or CT scans.<ref name="pmid2787035">{{cite journal |vauthors=Moore AD, Godwin JD, Müller NL, Naidich DP, Hammar SP, Buschman DL, Takasugi JE, de Carvalho CR |title=Pulmonary histiocytosis X: comparison of radiographic and CT findings |journal=Radiology |volume=172 |issue=1 |pages=249–54 |year=1989 |pmid=2787035 |doi=10.1148/radiology.172.1.2787035 |url=}}</ref>
*Thin-walled cystic cavities are the usual radiographic manifestation, observed in over 50% of patients by either CXR or CT scans.<ref name="pmid2787035">{{cite journal |vauthors=Moore AD, Godwin JD, Müller NL, Naidich DP, Hammar SP, Buschman DL, Takasugi JE, de Carvalho CR |title=Pulmonary histiocytosis X: comparison of radiographic and CT findings |journal=Radiology |volume=172 |issue=1 |pages=249–54 |year=1989 |pmid=2787035 |doi=10.1148/radiology.172.1.2787035 |url=}}</ref>
|
|
*Biopsy of the lung  
*Biopsy of the lung
|}
|}


=== '''The following table summarizes the differentiation of various lung tumors based on histological and topographical features:'''<ref name="pmid10682770">{{cite journal |vauthors=Erasmus JJ, Connolly JE, McAdams HP, Roggli VL |title=Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions |journal=Radiographics |volume=20 |issue=1 |pages=43–58 |date=2000 |pmid=10682770 |doi=10.1148/radiographics.20.1.g00ja0343 |url=}}</ref> ===
==='''The following table summarizes the differentiation of various lung tumors based on histological and topographical features:'''<ref name="pmid10682770">{{cite journal |vauthors=Erasmus JJ, Connolly JE, McAdams HP, Roggli VL |title=Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions |journal=Radiographics |volume=20 |issue=1 |pages=43–58 |date=2000 |pmid=10682770 |doi=10.1148/radiographics.20.1.g00ja0343 |url=}}</ref>===
{| class="wikitable"
{| class="wikitable"
! colspan="11" |Abrevations:  
! colspan="11" |Abrevations:  
Line 159: Line 159:
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Squamous cell papilloma]]'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Squamous cell papilloma]]'''
|
|
* [[Human papillomavirus|HPV 6]] and [[Human papillomavirus|11]]
*[[Human papillomavirus|HPV 6]] and [[Human papillomavirus|11]]
* Men
* Men
* Median age of diagnosis is 54 years
* Median age of diagnosis is 54 years
|
|
* [[Epithelial cells]]
*[[Epithelial cells]]
|
|
* Endobronchial
* Endobronchial
Line 174: Line 174:
* Acanthosis
* Acanthosis
* Binucleate forms and perinuclear halos
* Binucleate forms and perinuclear halos
* [[Koilocytosis]]
*[[Koilocytosis]]
|
|
* N/A
* N/A
Line 190: Line 190:
* Mean age of diagnosis is 68 years
* Mean age of diagnosis is 68 years
|
|
* [[Goblet cells]] of [[respiratory epithelium]]
*[[Goblet cells]] of [[respiratory epithelium]]
|
|
* Endobronchial
* Endobronchial
Line 220: Line 220:
* All lung lobes
* All lung lobes
* Lower lobes
* Lower lobes
* Hilar  
* Hilar
|
|
* 0.7-6.0 cm  
* 0.7-6.0 cm
* Well demarcated smooth
* Well demarcated smooth
* Lobulated, multicystic
* Lobulated, multicystic
Line 228: Line 228:
* Pale yellow to tan cut surfaces
* Pale yellow to tan cut surfaces
|
|
* Non-encapsulated  
* Non-encapsulated
* Multicystic masses
* Multicystic masses
* [[Cuboidal cells|Cuboidal cell]] linning
*[[Cuboidal cells|Cuboidal cell]] linning
* Squamous metaplasia  
* Squamous metaplasia
* Myxoid and [[Collagen|collagenous]] interstitium  
* Myxoid and [[Collagen|collagenous]] interstitium
|
|
* [[Keratin]]
*[[Keratin]]
* [[CEA]]
*[[CEA]]
* Surfactant protein  
* Surfactant protein
* [[TTF-1]]  
*[[TTF-1]]
* [[Actin]]
*[[Actin]]
|
|
* Well circumscribed
* Well circumscribed
Line 259: Line 259:
* Well defined
* Well defined
* Encapsulated
* Encapsulated
* Soft, spongy to firm mass  
* Soft, spongy to firm mass
* Granular gray white/ brown  
* Granular gray white/ brown
* 1.0- 4.0 cm  
* 1.0- 4.0 cm
|
|
* [[Infiltration (medical)|Infiltration]]  
*[[Infiltration (medical)|Infiltration]]
* [[Papillary]] growth pattern  
*[[Papillary]] growth pattern
* Fibrovascular cores  
* Fibrovascular cores
* [[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning
*[[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning
* Cilitated and oxyphilic cells  
* Cilitated and oxyphilic cells
* Occasional [[eosinophilic]] intranuclear inclusions
* Occasional [[eosinophilic]] intranuclear inclusions
|
|
* [[Cytokeratin]]
*[[Cytokeratin]]
* [[Clara cell secretory protein|Clara cell protein]]
*[[Clara cell secretory protein|Clara cell protein]]
* [[TTF-1]]
*[[TTF-1]]
* Surfactant apoprotein
* Surfactant apoprotein
* [[CEA]]
*[[CEA]]
|
|
* Incidental finding
* Incidental finding
Line 282: Line 282:
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenoma'''
|
|
* No sex predilection  
* No sex predilection
* Mean age of diagnosis is 52 years
* Mean age of diagnosis is 52 years
|
|
Line 289: Line 289:
* Central
* Central
|
|
* White-pink to tan  
* White-pink to tan
* Smooth and shiny tumors
* Smooth and shiny tumors
* Gelatinous mucoid solid core  
* Gelatinous mucoid solid core
* 0.7-7.5 cm
* 0.7-7.5 cm
|
|
* Numerous [[mucin]]-filled cystic spaces  
* Numerous [[mucin]]-filled cystic spaces
* Non-dilated microacini, glands, tubules and papillae
* Non-dilated microacini, glands, tubules and papillae
|
|
* EMA
* EMA
* [[Cytokeratin|Cytokeratins]]  
*[[Cytokeratin|Cytokeratins]]
* [[CEA]]
*[[CEA]]
|
|
* Coin lesion  
* Coin lesion
* Air-meniscus sign
* Air-meniscus sign
|
|
Line 321: Line 321:
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary'''
| rowspan="3" |
| rowspan="3" |
* Cigarette smokers  
* Cigarette smokers
* [[Arsenic]]  
*[[Arsenic]]
| rowspan="3" |
| rowspan="3" |
* Epithelial cells
* Epithelial cells
Line 329: Line 329:
| rowspan="3" |
| rowspan="3" |
* White or grey lesions
* White or grey lesions
* Focal carbon pigment deposits  
* Focal carbon pigment deposits
* [[Cavitation|Cavitations]]  
*[[Cavitation|Cavitations]]
* Intraluminal polypoid masses  
* Intraluminal polypoid masses
* [[Infiltration (medical)|Infiltration]]  
*[[Infiltration (medical)|Infiltration]]
|
|
* Exophytic  
* Exophytic
* Intra-epithelial
* Intra-epithelial
* Without invasion
* Without invasion
| rowspan="3" |
| rowspan="3" |
* [[Keratin]]  
*[[Keratin]]
* [[Cytokeratin|Cytokeratins]]  
*[[Cytokeratin|Cytokeratins]]
* [[CEA]]
*[[CEA]]
* [[Thyroid transcription factor-1]] ([[TTF-1]])  
*[[Thyroid transcription factor-1]] ([[TTF-1]])
| rowspan="3" |
| rowspan="3" |
* Lobar or entire lung collapse
* Lobar or entire lung collapse
* Shift of the [[mediastinum]] to the ipsilateral side
* Shift of the [[mediastinum]] to the ipsilateral side
* Hilar, perihilar or [[Mediastinal mass|mediastinal masses]]  
* Hilar, perihilar or [[Mediastinal mass|mediastinal masses]]
| rowspan="3" |
| rowspan="3" |
* [[Liver]]
*[[Liver]]
* [[Breast]]
*[[Breast]]
* [[Bone]]
*[[Bone]]
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell'''
Line 362: Line 362:
| colspan="3" style="background:#DCDCDC;" align="center" + |'''[[Small cell carcinoma]]'''<ref name="pmid16226617">{{cite journal |vauthors=Jackman DM, Johnson BE |title=Small-cell lung cancer |journal=Lancet |volume=366 |issue=9494 |pages=1385–96 |date=2005 |pmid=16226617 |doi=10.1016/S0140-6736(05)67569-1 |url=}}</ref>
| colspan="3" style="background:#DCDCDC;" align="center" + |'''[[Small cell carcinoma]]'''<ref name="pmid16226617">{{cite journal |vauthors=Jackman DM, Johnson BE |title=Small-cell lung cancer |journal=Lancet |volume=366 |issue=9494 |pages=1385–96 |date=2005 |pmid=16226617 |doi=10.1016/S0140-6736(05)67569-1 |url=}}</ref>
|
|
* [[Smoking]]
*[[Smoking]]
* [[Radon]] exposure
*[[Radon]] exposure
|
|
* Bronchial precursor cell
* Bronchial precursor cell
|
|
* Peripheral  
* Peripheral
|
|
* White-tan, soft, friable perihilar masses  
* White-tan, soft, friable perihilar masses
* Extensive necrosis  
* Extensive necrosis
* 5% peripheral coin lesions
* 5% peripheral coin lesions
|
|
* Sheet-like growth
* Sheet-like growth
* Nesting  
* Nesting
* Trabeculae
* Trabeculae
* Peripheral palisading
* Peripheral palisading
* Rosette formation
* Rosette formation
* High mitotic rate  
* High mitotic rate
|
|
* [[CD56]]
*[[CD56]]
* [[Chromogranin]]
*[[Chromogranin]]
* [[Synaptophysin]]  
*[[Synaptophysin]]
* [[TTF-1]]
*[[TTF-1]]
|
|
* Hilar or perihilar masses  
* Hilar or perihilar masses
* [[Mediastinal lymphadenopathy]]  
*[[Mediastinal lymphadenopathy]]
* Lobar collapse
* Lobar collapse
|
|
* Bone marrow  
* Bone marrow
* Liver
* Liver
|-
|-
Line 395: Line 395:
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Acinar adenocarcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Acinar adenocarcinoma'''
| rowspan="10" |
| rowspan="10" |
* [[Smoking]]
*[[Smoking]]
| rowspan="10" |
| rowspan="10" |
* Columnar cells of bronchioles
* Columnar cells of bronchioles
Line 405: Line 405:
* Peripheral distribution
* Peripheral distribution
* Gray-white central fibrosis
* Gray-white central fibrosis
* [[Pleural]] puckering  
*[[Pleural]] puckering
* Anthracotic pigmentation
* Anthracotic pigmentation
** [[Necrosis]]  
**[[Necrosis]]
** [[Cavitation]]
**[[Cavitation]]
** [[Hemorrhage]]
**[[Hemorrhage]]
* Lobulated or ill defined edges
* Lobulated or ill defined edges
|
|
* Irregular-shaped glands
* Irregular-shaped glands
* [[Malignant]] cells:  
*[[Malignant]] cells:  
** Hyperchromatic nuclei  
** Hyperchromatic nuclei
** Fibroblastic stroma
** Fibroblastic stroma
| rowspan="10" |
| rowspan="10" |
* Epithelial markers
* Epithelial markers
* [[CEA]]
*[[CEA]]
* [[Cytokeratin|CK7]]  
*[[Cytokeratin|CK7]]
* [[TTF-1]]
*[[TTF-1]]
| rowspan="10" |
| rowspan="10" |
* Peripheral nodules under 4.0 cm in size
* Peripheral nodules under 4.0 cm in size
* Central location as a hilar or perihilar mass  
* Central location as a hilar or perihilar mass
* Rarely show cavitations.
* Rarely show cavitations.
* Hilar adenopathy  
* Hilar adenopathy
* Adenocarcinomas account for the majority of small peripheral cancers identified radiologically.  
* Adenocarcinomas account for the majority of small peripheral cancers identified radiologically.
| rowspan="10" |Aerogenous spread is characteristic
| rowspan="10" |Aerogenous spread is characteristic
* Brain
* Brain
* Bone
* Bone
Line 437: Line 438:
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary adenocarcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary adenocarcinoma'''
|
|
* [[Papillae]]  
*[[Papillae]]
* [[Necrosis]]
*[[Necrosis]]
* Surrounding invasion
* Surrounding invasion
* [[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning
*[[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning
* [[Mucinous]] or non-mucinous
*[[Mucinous]] or non-mucinous
|-
|-
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Bronchio-alveolar carcinoma'''
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Bronchio-alveolar carcinoma'''
| style="background:#DCDCDC;" align="center" + |'''Non-mucinous'''
| style="background:#DCDCDC;" align="center" + |'''Non-mucinous'''
|
|
* [[Clara cell|Clara cells]]
*[[Clara cell|Clara cells]]
* [[Pneumocytes|Type II cells]]
*[[Pneumocytes|Type II cells]]
|-
|-
| style="background:#DCDCDC;" align="center" + |'''Mucinous'''
| style="background:#DCDCDC;" align="center" + |'''Mucinous'''
Line 453: Line 454:
* Low grade differentiation
* Low grade differentiation
* Composed of:  
* Composed of:  
** Tall [[Columnar epithelia|columnar cells]]  
** Tall [[Columnar epithelia|columnar cells]]
** Basal nuclei
** Basal nuclei
** Pale cytoplasm resembling goblet cells
** Pale cytoplasm resembling goblet cells
** Varying amounts of cytoplasmic mucin  
** Varying amounts of cytoplasmic mucin
* Cytologic atypia  
* Cytologic atypia
|-
|-
| style="background:#DCDCDC;" align="center" + |'''Mixed non-mucinous and mucinous or indeterminate'''
| style="background:#DCDCDC;" align="center" + |'''Mixed non-mucinous and mucinous or indeterminate'''
Line 479: Line 480:
| style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenocarcinoma'''
| style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenocarcinoma'''
|
|
* Partial [[fibrous tissue]] capsule  
* Partial [[fibrous tissue]] capsule
* Central [[cystic]] change with [[mucin]] pooling  
* Central [[cystic]] change with [[mucin]] pooling
* [[Neoplastic]] [[mucinous]] [[epithelium]] grows along alveolar walls
*[[Neoplastic]] [[mucinous]] [[epithelium]] grows along alveolar walls
|-
|-
| style="background:#DCDCDC;" align="center" + |'''Signet ring adenocarcinoma'''
| style="background:#DCDCDC;" align="center" + |'''Signet ring adenocarcinoma'''
|
|
* Focal  
* Focal
* Cells with nuclei displaced to sides
* Cells with nuclei displaced to sides
* Components of other cells are present.
* Components of other cells are present.
Line 507: Line 508:
| rowspan="5" |
| rowspan="5" |
* Approximately 10% of lung cancers
* Approximately 10% of lung cancers
* [[Smoking]]
*[[Smoking]]
| rowspan="5" |
| rowspan="5" |
* [[Neuroendocrine cells|Neuro endocrine cells]]
*[[Neuroendocrine cells|Neuro endocrine cells]]
* Suprabasal bronchial cells
* Suprabasal bronchial cells
| rowspan="5" |
| rowspan="5" |
* Peripheral masses
* Peripheral masses
* [[Bronchi]]
*[[Bronchi]]
| rowspan="5" |
| rowspan="5" |
* Soft, pink-tan tumor  
* Soft, pink-tan tumor


* [[Necrosis]] and occasional [[hemorrhage]]
*[[Necrosis]] and occasional [[hemorrhage]]
* [[Cavitation|Cavitations]]  
*[[Cavitation|Cavitations]]
* Exophytic bronchial growth  
* Exophytic bronchial growth
|
|
*Invasive growth pattern
*Invasive growth pattern
Line 532: Line 533:
* Large, peripheral masses
* Large, peripheral masses
| rowspan="5" |
| rowspan="5" |
* [[Pleura]]
*[[Pleura]]
* [[Liver]]
*[[Liver]]
* [[Bone]]
*[[Bone]]
* [[Brain]]
*[[Brain]]
* Abdominal [[Lymph node|lymph nodes]]
* Abdominal [[Lymph node|lymph nodes]]
* [[Pericardium]]
*[[Pericardium]]
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell carcinoma of the lung'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell carcinoma of the lung'''
|
|
* [[Clear cell|Clear cells]]
*[[Clear cell|Clear cells]]
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Lymphoepithelioma-like carcinoma of the lung'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Lymphoepithelioma-like carcinoma of the lung'''
|
|
* Syncytial growth pattern
* Syncytial growth pattern
* [[Eosinophilic]] nucleoli
*[[Eosinophilic]] nucleoli
* [[Lymphocyte|Lymphocytic]] infiltration
*[[Lymphocyte|Lymphocytic]] infiltration
* Invasive
* Invasive
* [[Amyloid]] deposition
*[[Amyloid]] deposition
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Large-cell lung carcinoma with rhabdoid phenotype'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Large-cell lung carcinoma with rhabdoid phenotype'''
|
|
* [[Eosinophilic]] [[cytoplasmic]] globules
*[[Eosinophilic]] [[cytoplasmic]] globules
* Small foci of [[adenocarcinoma]]
* Small foci of [[adenocarcinoma]]
* [[Eosinophilic]] inclusions
*[[Eosinophilic]] inclusions
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mixed type'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mixed type'''
|
|
* Mixture of:  
* Mixture of:  
** [[Adenocarcinoma]]
**[[Adenocarcinoma]]
** [[Squamous cell carcinoma]]
**[[Squamous cell carcinoma]]
** Giant cell carcinoma
** Giant cell carcinoma
** Spindle cell carcinoma
** Spindle cell carcinoma
Line 581: Line 582:
* Mean age at diagnosis is 60 years
* Mean age at diagnosis is 60 years
* Tobacco [[smoking]]
* Tobacco [[smoking]]
* [[Asbestos|Asbestos exposure]]
*[[Asbestos|Asbestos exposure]]
| rowspan="5" |
| rowspan="5" |
* Undifferentiated [[epithelial cells]]  
* Undifferentiated [[epithelial cells]]
| rowspan="5" |
| rowspan="5" |
* Central or peripheral
* Central or peripheral
Line 589: Line 590:
| rowspan="5" |
| rowspan="5" |
* > 5 cm
* > 5 cm
* Well circumscribed  
* Well circumscribed
* Grey, yellow or tan creamy, gritty,  
* Grey, yellow or tan creamy, gritty,
* Mucoid and/or [[hemorrhagic]] with significant [[necrosis]]
* Mucoid and/or [[hemorrhagic]] with significant [[necrosis]]
* [[Sessile]] or [[pedunculated]]  
*[[Sessile]] or [[pedunculated]]
* Infiltrative
* Infiltrative
|
|
Line 598: Line 599:
* Mixture of [[carcinomatous]] and sarcomatous cells
* Mixture of [[carcinomatous]] and sarcomatous cells
|
|
* [[Keratin]]  
*[[Keratin]]
* [[S-100]]
*[[S-100]]
| rowspan="5" |
| rowspan="5" |
* No specific imaging features 
* No specific imaging features 
| rowspan="5" |
| rowspan="5" |
* Aggressive tumor
* Aggressive tumor
* [[Esophagus]], [[jejunum]], and [[rectum]]
*[[Esophagus]], [[jejunum]], and [[rectum]]
* [[Kidney]]
*[[Kidney]]
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Spindle cell carcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Spindle cell carcinoma'''
Line 612: Line 613:
* Lymphoplasmacytic infiltrates
* Lymphoplasmacytic infiltrates
| rowspan="3" |
| rowspan="3" |
* [[Keratin]]  
*[[Keratin]]
* EMA  
* EMA
* [[Cytokeratin]]
*[[Cytokeratin]]
* [[Vimentin]]
*[[Vimentin]]
* [[CEA]]
*[[CEA]]
* [[TTF-1]]  
*[[TTF-1]]
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Giant cell carcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Giant cell carcinoma'''
Line 631: Line 632:
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary blastoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary blastoma'''
|
|
* Biphasic  
* Biphasic
* Mixture of [[Epithelium|epithelial]] and  mesenchymal [[Stromal cell|stroma]]
* Mixture of [[Epithelium|epithelial]] and  mesenchymal [[Stromal cell|stroma]]
|
|
* [[Keratin]]
*[[Keratin]]
* EMA  
* EMA
* [[CEA]]  
*[[CEA]]
* [[Chromogranin A]]  
*[[Chromogranin A]]
|-
|-
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
Line 651: Line 652:
| style="background:#DCDCDC;" align="center" + |'''[[Carcinoid tumor]]'''<ref name="pmid19212636">{{cite journal |vauthors=Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S |title=Lung carcinoid tumor biology: treatment and survival |journal=Oncol. Rep. |volume=21 |issue=3 |pages=757–60 |date=March 2009 |pmid=19212636 |doi= |url=}}</ref>
| style="background:#DCDCDC;" align="center" + |'''[[Carcinoid tumor]]'''<ref name="pmid19212636">{{cite journal |vauthors=Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S |title=Lung carcinoid tumor biology: treatment and survival |journal=Oncol. Rep. |volume=21 |issue=3 |pages=757–60 |date=March 2009 |pmid=19212636 |doi= |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Typical carcinoid'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Typical carcinoid'''
'''Atypical carcinoid'''  
'''Atypical carcinoid'''
|
|
* Most common in males
* Most common in males
* Mean age of diagnosis 45
* Mean age of diagnosis 45
|
|
* [[Neuroendocrine cells]] of lung
*[[Neuroendocrine cells]] of lung
|
|
* Typical [[Carcinoid|carcinoids]] are throughout the lungs  
* Typical [[Carcinoid|carcinoids]] are throughout the lungs


* Atypical carcinoid is more commonly peripheral
* Atypical carcinoid is more commonly peripheral
|
|
* Firm, well demarcated, tan to yellow tumors  
* Firm, well demarcated, tan to yellow tumors
|
|
* Uniform polygonal cells  
* Uniform polygonal cells
* Nuclear atypia  
* Nuclear atypia
* [[Pleomorphism]]  
*[[Pleomorphism]]
* The most common patterns are the organoid and trabecular  
* The most common patterns are the organoid and trabecular
* Highly vascularized fibrovascular stroma
* Highly vascularized fibrovascular stroma
* Focal [[necrosis]]
* Focal [[necrosis]]
|
|
* [[Cytokeratin]]  
*[[Cytokeratin]]
* [[Chromogranin]]
*[[Chromogranin]]
* [[Synaptophysin]]
*[[Synaptophysin]]
* [[CD57]]  
*[[CD57]]
* [[CD56]]  
*[[CD56]]
* [[S-100 protein]]
*[[S-100 protein]]
|
|
* Well defined [[pulmonary]] nodules
* Well defined [[pulmonary]] nodules
* [[Calcification|Calcifications]] is often seen.  
*[[Calcification|Calcifications]] is often seen.
* Intense contrast enhancement
* Intense contrast enhancement
|
|
* [[Liver]]  
*[[Liver]]
* [[Bone]]
*[[Bone]]
|-
|-
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Salivary gland tumors'''<ref name="pmid23789697">{{cite journal |vauthors=Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM |title=Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome |journal=AJR Am J Roentgenol |volume=201 |issue=1 |pages=W57–63 |date=July 2013 |pmid=23789697 |pmc=3767141 |doi=10.2214/AJR.12.9579 |url=}}</ref>  
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Salivary gland tumors'''<ref name="pmid23789697">{{cite journal |vauthors=Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM |title=Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome |journal=AJR Am J Roentgenol |volume=201 |issue=1 |pages=W57–63 |date=July 2013 |pmid=23789697 |pmc=3767141 |doi=10.2214/AJR.12.9579 |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Mucoepidermoid carcinoma]]'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Mucoepidermoid carcinoma]]'''
|
|
Line 697: Line 698:
|
|
* Ranging in size from 0.5-6 cm
* Ranging in size from 0.5-6 cm
* Soft, polypoid, and pink-tan in colour  
* Soft, polypoid, and pink-tan in colour
* High-grade lesions are infiltrative
* High-grade lesions are infiltrative
|
|
Line 705: Line 706:
* Transitional areas to low grade [[mucoepidermoid carcinoma]]
* Transitional areas to low grade [[mucoepidermoid carcinoma]]
|
|
* [[GFAP]]
*[[GFAP]]
|
|
* Well-circumscribed oval or lobulated mass
* Well-circumscribed oval or lobulated mass
* [[Calcification|Calcifications]]
*[[Calcification|Calcifications]]
* Post-obstructive pneumonic infiltrates
* Post-obstructive pneumonic infiltrates
|
|
* Rare
* Rare
* [[Liver]]
*[[Liver]]
* [[Bones]]
*[[Bones]]
* [[Adrenal gland]]
*[[Adrenal gland]]
* [[Brain]]
*[[Brain]]
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Adenoid cystic carcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Adenoid cystic carcinoma'''
Line 724: Line 725:
* Primitive cells of tracheobronchial origin
* Primitive cells of tracheobronchial origin
|
|
* [[Trachea]]
*[[Trachea]]
|
|
* Gray-white or tan polypoid lesions
* Gray-white or tan polypoid lesions


* Size ranges from 1–4 cm  
* Size ranges from 1–4 cm


* Infiltrative margins
* Infiltrative margins
Line 734: Line 735:
* Invades other cell layers
* Invades other cell layers
* Heterogeneous cellularity
* Heterogeneous cellularity
* Cribriform pattern  
* Cribriform pattern
* Perineural invasion
* Perineural invasion
|
|
* [[Immunoperoxidase]]  
*[[Immunoperoxidase]]
* [[Cytokeratin]]  
*[[Cytokeratin]]
* [[Vimentin]]
*[[Vimentin]]
* [[Actin]]
*[[Actin]]
* [[Calponin]]
*[[Calponin]]
* [[S-100 protein]]
*[[S-100 protein]]
* [[p53]]  
*[[p53]]
* [[GFAP]]
*[[GFAP]]
|
|
* Well circumscribed
* Well circumscribed
* Nodule
* Nodule
|
|
* [[Liver]]
*[[Liver]]
* [[Brain]]
*[[Brain]]
* [[Bone]]
*[[Bone]]
* [[Spleen]]
*[[Spleen]]
* [[Kidney]]
*[[Kidney]]
* [[Adrenal glands]]
*[[Adrenal glands]]
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelial-myoepithelial carcinoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelial-myoepithelial carcinoma'''
|
|
* Age ranges from 33 to 71 years  
* Age ranges from 33 to 71 years
* No association with [[smoking]]
* No association with [[smoking]]
|
|
Line 768: Line 769:
* White to gray in colour
* White to gray in colour
|
|
* [[Myoepithelial cells]]
*[[Myoepithelial cells]]
* Dual layer of cells lining ducts
* Dual layer of cells lining ducts
* Low mitotic activity
* Low mitotic activity
|
|
* MNF116  
* MNF116
* EMA
* EMA
* [[SMA]] and [[S-100]]
*[[SMA]] and [[S-100]]
|
|
* Reflects [[airway obstruction]]
* Reflects [[airway obstruction]]
|
|
* [[Breast]]
*[[Breast]]
|-
|-
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma
Line 790: Line 791:
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
|-
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Preinvasive lesions'''<ref name="pmid11980589">{{cite journal |vauthors=Greenberg AK, Yee H, Rom WN |title=Preneoplastic lesions of the lung |journal=Respir. Res. |volume=3 |issue= |pages=20 |date=2002 |pmid=11980589 |pmc=107849 |doi= |url=}}</ref>  
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Preinvasive lesions'''<ref name="pmid11980589">{{cite journal |vauthors=Greenberg AK, Yee H, Rom WN |title=Preneoplastic lesions of the lung |journal=Respir. Res. |volume=3 |issue= |pages=20 |date=2002 |pmid=11980589 |pmc=107849 |doi= |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Squamous carcinoma in situ'''  
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Squamous carcinoma in situ'''
| rowspan="3" |
| rowspan="3" |
* Most commonly seen in fifth or sixth decades
* Most commonly seen in fifth or sixth decades
Line 798: Line 799:
* Basal cells of squamous epithelium
* Basal cells of squamous epithelium
|
|
* [[Bronchi]]
*[[Bronchi]]
|
|
* Focal or multi-focal plaque-like greyish lesions  
* Focal or multi-focal plaque-like greyish lesions
* Nonspecific [[erythema]]  
* Nonspecific [[erythema]]
* Even nodular or polypoid lesions
* Even nodular or polypoid lesions
|
|
* [[Goblet cell]] [[hyperplasia]]
*[[Goblet cell]] [[hyperplasia]]


* [[Basal cell]] [[hyperplasia]]
*[[Basal cell]] [[hyperplasia]]


* [[Squamous]] [[dysplasia]]  
*[[Squamous]] [[dysplasia]]


* [[Angiogenic]] [[squamous]] [[dysplasia]]  
*[[Angiogenic]] [[squamous]] [[dysplasia]]


* Micropapillomatosis
* Micropapillomatosis
|
|
* [[EGFR]]  
*[[EGFR]]
* [[HER2/neu]]
*[[HER2/neu]]
* [[P53 (protein)|p53]]  
*[[P53 (protein)|p53]]
* [[MCM2]]  
*[[MCM2]]
* [[Ki-67]]  
*[[Ki-67]]
* [[Cytokeratin|Cytokeratin 5/6]]  
*[[Cytokeratin|Cytokeratin 5/6]]
* [[Bcl-2]]  
*[[Bcl-2]]
* [[VEGF]]  
*[[VEGF]]
* Folate binding protein  
* Folate binding protein
* [[P16 (gene)|p16]]
*[[P16 (gene)|p16]]
|
|
* Cauliflower like
* Cauliflower like
* Mosaic pattern
* Mosaic pattern
| rowspan="3" |
| rowspan="3" |
* [[Liver]]
*[[Liver]]
* [[Brain]]
*[[Brain]]
* [[Bone]]
*[[Bone]]
* [[Spleen]]
*[[Spleen]]
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Atypical adenomatous hyperplasia'''  
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Atypical adenomatous hyperplasia'''
|
|
* Surfactant apoprotein  
* Surfactant apoprotein
* [[Clara cell secretory protein|Clara cell specific 10kDd protein]]
*[[Clara cell secretory protein|Clara cell specific 10kDd protein]]
|
|
* [[Pleurae|Pleura]]  
*[[Pleurae|Pleura]]
* Upper lobes
* Upper lobes
|
|
* Multiple grey to yellow foci  
* Multiple grey to yellow foci
* 1mm to 10mm in size
* 1mm to 10mm in size
|
|
* Intranuclear inclusions
* Intranuclear inclusions
* [[Clara cell|Clara cells]] and [[Pneumocytes|type II pneumocytes]]  
*[[Clara cell|Clara cells]] and [[Pneumocytes|type II pneumocytes]]
* Thickened alveolar walls  
* Thickened alveolar walls
* Discontinuous lining of cells
* Discontinuous lining of cells
* Moderate atypia
* Moderate atypia
* Pseudopapillae
* Pseudopapillae
|
|
* [[CEA]]  
*[[CEA]]
* [[MMP|MMPs]]  
*[[MMP|MMPs]]
* [[E-cadherin]]  
*[[E-cadherin]]
* [[Beta-catenin|ß-catenin]]
*[[Beta-catenin|ß-catenin]]
* [[CD44|CD44v6]]  
*[[CD44|CD44v6]]
* [[TTF-1]]
*[[TTF-1]]
* [[TP53]]  
*[[TP53]]
|
|
* Typically not visualized on [[Radiography|radiographs]]
* Typically not visualized on [[Radiography|radiographs]]
* Small non-solid nodules
* Small non-solid nodules


* Ground-glass opacity  
* Ground-glass opacity
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia'''
|
|
* [[Pulmonary]] [[neuroendocrine cells]]
*[[Pulmonary]] [[neuroendocrine cells]]
|
|
* Endobronchial
* Endobronchial
Line 872: Line 873:
* Early lesions are:
* Early lesions are:
** Small, gray-white nodules
** Small, gray-white nodules
** Resembling ‘miliary bodies’  
** Resembling ‘miliary bodies’
* Larger [[carcinoid]] tumors are:
* Larger [[carcinoid]] tumors are:
** Firm
** Firm
** Homogeneous
** Homogeneous
** Well-defined
** Well-defined
** Grey or yellow-white masses  
** Grey or yellow-white masses
|
|
* [[Nodular]] aggregates
*[[Nodular]] aggregates
* [[Myelofibrosis|Fibrosis]] due to [[proliferation]]
*[[Myelofibrosis|Fibrosis]] due to [[proliferation]]
* Invade locally
* Invade locally
* [[Fibrous]] [[stroma]] aggregates to form ‘tumorlets’.
*[[Fibrous]] [[stroma]] aggregates to form ‘tumorlets’.
* [[Carcinoid|Carcinoids]] are tumorlets >5cm.
*[[Carcinoid|Carcinoids]] are tumorlets >5cm.
|
|
* [[Keratin]]
*[[Keratin]]
* [[CEA]]
*[[CEA]]
|
|
* Mosaic pattern of air trapping
* Mosaic pattern of air trapping
Line 902: Line 903:
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis
|-
|-
| rowspan="8" style="background:#DCDCDC;" align="center" + |'''Mesenchymal tumors'''<ref name="pmid24407922">{{cite journal |vauthors=Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP |title=Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms |journal=Insights Imaging |volume=5 |issue=2 |pages=237–44 |date=April 2014 |pmid=24407922 |pmc=3999366 |doi=10.1007/s13244-013-0306-0 |url=}}</ref>  
| rowspan="8" style="background:#DCDCDC;" align="center" + |'''Mesenchymal tumors'''<ref name="pmid24407922">{{cite journal |vauthors=Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP |title=Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms |journal=Insights Imaging |volume=5 |issue=2 |pages=237–44 |date=April 2014 |pmid=24407922 |pmc=3999366 |doi=10.1007/s13244-013-0306-0 |url=}}</ref>
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelioid haemangioendothelioma / Angiosarcoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelioid haemangioendothelioma / Angiosarcoma'''
|
|
Line 910: Line 911:
* Endothelial cells
* Endothelial cells
|
|
* [[Intravascular]]
*[[Intravascular]]
|
|
* 0.3-2.0 cm circumscribed mass
* 0.3-2.0 cm circumscribed mass
Line 916: Line 917:
* Yellow flecks
* Yellow flecks
* Central [[Calcification|calcifications]]
* Central [[Calcification|calcifications]]
* Cut surface has a [[cartilaginous]] consistency
* Cut surface has a [[cartilaginous]] consistency
|
|
* Round to oval-shaped [[nodules]]
* Round to oval-shaped [[nodules]]
* Central [[sclerosis]]
* Central [[sclerosis]]
* Hypocellular zone  
* Hypocellular zone
* Peripheral cellular zone
* Peripheral cellular zone
* [[Calcification|Calcifications]]
*[[Calcification|Calcifications]]
* Intranuclear [[cytoplasmic]] [[inclusions]]
* Intranuclear [[cytoplasmic]] [[inclusions]]
|
|
* [[CD31]]
*[[CD31]]
* [[CD34]]
*[[CD34]]
* [[Factor VIII]] ([[von Willebrand factor]])
*[[Factor VIII]] ([[von Willebrand factor]])
* [[Cytokeratin]]  
*[[Cytokeratin]]
|
|
* Multiple
* Multiple
* Bilateral
* Bilateral
* Small nodules  
* Small nodules
* 1-2 cm in size  
* 1-2 cm in size
* Can mimic [[Langerhans cell histiocytosis|pulmonary Langerhans’ cell histiocytosis]].
* Can mimic [[Langerhans cell histiocytosis|pulmonary Langerhans’ cell histiocytosis]].
* [[Calcification|Calcifications]]
*[[Calcification|Calcifications]]
|
|
* [[Liver]]
*[[Liver]]
* [[Bone]]  
*[[Bone]]
* [[Soft tissue]]
*[[Soft tissue]]
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pleuropulmonary blastoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pleuropulmonary blastoma'''
Line 946: Line 947:
* Median age of diagnosis is 2 years
* Median age of diagnosis is 2 years
|
|
* [[Thoracic]] splanchnopleural [[mesenchyme]]
*[[Thoracic]] splanchnopleural [[mesenchyme]]
|
|
* [[Pleurae|Pleura]]  
*[[Pleurae|Pleura]]
* [[Lung]]
*[[Lung]]
|
|
* Purely cystic  
* Purely cystic
* Thin-walled  
* Thin-walled
* Rarely solid
* Rarely solid
* Firm to gelatinous
* Firm to gelatinous
Line 966: Line 967:
** Mixed cells
** Mixed cells
|
|
* [[Vimentin]]
*[[Vimentin]]
* [[S-100 protein]]
*[[S-100 protein]]
|
|
* Unilateral  
* Unilateral
* Localized airfilled cysts
* Localized airfilled cysts
* Septal thickening or an intracystic mass
* Septal thickening or an intracystic mass
|
|
* [[Brain]]
*[[Brain]]
* [[Spinal cord]]  
*[[Spinal cord]]
* [[Skeletal system]]
*[[Skeletal system]]
* [[Eye|Eyes]]
*[[Eye|Eyes]]
* [[Pancreas]]
*[[Pancreas]]
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Chondroma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Chondroma'''
Line 983: Line 984:
* Young women
* Young women
|
|
* [[Chondrocyte|Chondrocytes]]  
*[[Chondrocyte|Chondrocytes]]
* Cartilaginous cells
* Cartilaginous cells
|
|
* Peripheral lesions in [[lung]]
* Peripheral lesions in [[lung]]
* Primary lesion seen in
* Primary lesion seen in
** [[Stomach]]
**[[Stomach]]
** [[Bone]]
**[[Bone]]
** [[Paraganglia]]
**[[Paraganglia]]
|
|
* Peripheral  
* Peripheral
* Solid lesions
* Solid lesions
* [[Calcified lesion|Calcified]]
*[[Calcified lesion|Calcified]]
|
|
* Capsulated lobules  
* Capsulated lobules
* Hypocellular
* Hypocellular
* Features of [[malignancy]] are absent
* Features of [[malignancy]] are absent
Line 1,006: Line 1,007:
* “Pop-corn” calcifications
* “Pop-corn” calcifications
|
|
* [[Benign tumor|Benign]] in nature
*[[Benign tumor|Benign]] in nature
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Congenital peribronchial myofibroblastic tumor'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Congenital peribronchial myofibroblastic tumor'''
Line 1,013: Line 1,014:
* Sporadic
* Sporadic
* Complicated by  
* Complicated by  
** [[Polyhydramnios]]  
**[[Polyhydramnios]]
** [[Hydrops fetalis|Non-immune hydrops fetalis]]
**[[Hydrops fetalis|Non-immune hydrops fetalis]]
|
|
* [[Spindle cells]]
*[[Spindle cells]]
|
|
* Along the bronchi
* Along the bronchi
|
|
* 5-10 cm  
* 5-10 cm
* Well-circumscribed
* Well-circumscribed
* Non-encapsulated
* Non-encapsulated
* Smooth or multinodular surface
* Smooth or multinodular surface
* The cut surface has a tann-grey to yellow-tan fleshy appearance
* The cut surface has a tann-grey to yellow-tan fleshy appearance
* [[Hemorrhage]]  
*[[Hemorrhage]]
* [[Necrosis]]
*[[Necrosis]]
|
|
* [[Fascicles]] of [[spindle cells]]
*[[Fascicles]] of [[spindle cells]]
* [[Bronchial]] invasion  
*[[Bronchial]] invasion
* Peribronchial distribution
* Peribronchial distribution
* Cystic foci of [[hemorrhage]]
* Cystic foci of [[hemorrhage]]
|
|
* [[Vimentin]]
*[[Vimentin]]
|
|
* Well circumscribed  
* Well circumscribed
* Opaque hemithorax
* Opaque hemithorax
* Heterogeneous mass
* Heterogeneous mass
Line 1,046: Line 1,047:
* Young adults of both sexes
* Young adults of both sexes
|
|
* [[Smooth muscle cells]] of [[lymphatic vessels]]
*[[Smooth muscle cells]] of [[lymphatic vessels]]
|
|
* Along the [[Lymphatic drainage|lymphatic distribution]]
* Along the [[Lymphatic drainage|lymphatic distribution]]
|
|
* Prominence of the bronchovascular bundles along
* Prominence of the bronchovascular bundles along
** [[Pleurae|Pleura]]
**[[Pleurae|Pleura]]
** Interlobular pulmonary septa
** Interlobular pulmonary septa
** [[Mediastinum]]
**[[Mediastinum]]
|
|
* Anastomosing endothelial-lined cells along lymphatic routes
* Anastomosing endothelial-lined cells along lymphatic routes


* [[Spindle cells]]
*[[Spindle cells]]
* Intra alveolar siderophages
* Intra alveolar siderophages
|
|
* [[Vimentin]]  
*[[Vimentin]]
|
|
* Increased interstitial markings
* Increased interstitial markings


* Thickening of the:  
* Thickening of the:  
** Interlobular septa  
** Interlobular septa
** [[Fissure|Fissures]]
**[[Fissure|Fissures]]
** Central airways  
** Central airways
** [[Pleura]]
**[[Pleura]]
|
|
* Skin
* Skin
Line 1,076: Line 1,077:
|
|
* Previous [[viral infections]]
* Previous [[viral infections]]
* [[HHV-8|HHV8]]
*[[HHV-8|HHV8]]
* Children
* Children
|
|
* [[Myofibroblasts|Myofibroblastic cells]]
*[[Myofibroblasts|Myofibroblastic cells]]
|
|
* Localized to bronchi
* Localized to bronchi
Line 1,089: Line 1,090:
* Yellowish-gray discoloration
* Yellowish-gray discoloration
* Average size of 3.0 cm
* Average size of 3.0 cm
* Non-encapculated  
* Non-encapculated
* [[Calcification|Calcifications]]  
*[[Calcification|Calcifications]]
* No local invasion
* No local invasion
|
|
* Mixture of [[spindle cells]]  
* Mixture of [[spindle cells]]  
** [[Fibroblastic]]  
**[[Fibroblastic]]
** [[Myofibroblasts|Myofibroblastic]]
**[[Myofibroblasts|Myofibroblastic]]
* Arranged in [[fascicles]]  
* Arranged in [[fascicles]]
* Cytologic atypia  
* Cytologic atypia
* Touton type [[giant cells]]
* Touton type [[giant cells]]
* [[Plasma cells]]  
*[[Plasma cells]]
* [[Lymphoid follicles]]
*[[Lymphoid follicles]]
|
|
* [[Vimentin]]  
*[[Vimentin]]
* [[Actin]]
*[[Actin]]
* p80
* p80
|
|
* Solitary mass
* Solitary mass
* Regular borders  
* Regular borders
* Spiculated appearance
* Spiculated appearance
* Accompanied by  
* Accompanied by  
** Post-obstructive [[pneumonia]]  
** Post-obstructive [[pneumonia]]
** [[Atelectasis]]
**[[Atelectasis]]
|
|
* Rare
* Rare
Line 1,120: Line 1,121:
* Commonly misdiagnosed as [[pulmonary embolism]]
* Commonly misdiagnosed as [[pulmonary embolism]]
|
|
* [[Mesenchymal cell|Mesenchymal cells]] of the [[intima]]  
*[[Mesenchymal cell|Mesenchymal cells]] of the [[intima]]
* Primitive cells of the bulbus cordi in the trunk of [[pulmonary artery]]
* Primitive cells of the bulbus cordi in the trunk of [[pulmonary artery]]
|
|
* [[Pulmonary trunk]] most commonly involving:
*[[Pulmonary trunk]] most commonly involving:
** [[Right pulmonary artery]]
**[[Right pulmonary artery]]
** [[Left pulmonary artery]]
**[[Left pulmonary artery]]
** [[Pulmonary valve]]
**[[Pulmonary valve]]
** [[Ventricular outflow tract|Right ventricular outflow tract]]
**[[Ventricular outflow tract|Right ventricular outflow tract]]
|
|
* Mucoid or gelatinous clots filling vascular lumens
* Mucoid or gelatinous clots filling vascular lumens
Line 1,133: Line 1,134:
** Firm fibrotic areas
** Firm fibrotic areas
** Bony/gritty or chondromyxoid foci
** Bony/gritty or chondromyxoid foci
** [[Hemorrhage]] and [[necrosis]] are common in high-grade tumors
**[[Hemorrhage]] and [[necrosis]] are common in high-grade tumors
|
|
* Spindle cells in
* Spindle cells in
** A myxoid background
** A myxoid background
** Collagenized stroma
** Collagenized stroma
** Recanalized thrombi  
** Recanalized thrombi
|
|
* [[Vimentin]]
*[[Vimentin]]
* [[Osteopontin]]
*[[Osteopontin]]
* [[Factor VIII]]
*[[Factor VIII]]
* [[CD31]]
*[[CD31]]
* [[CD34]]
*[[CD34]]
| rowspan="2" |
| rowspan="2" |
* Findings overlap with those of chronic [[thromboembolic disease]]
* Findings overlap with those of chronic [[thromboembolic disease]]
* Decreased [[vascularity]]  
* Decreased [[vascularity]]
* Heterogeneous [[soft tissue]] density
* Heterogeneous [[soft tissue]] density
* Smooth [[vascular]] tapering  
* Smooth [[vascular]] tapering
|
|
* [[Lung]] parenchyma  
*[[Lung]] parenchyma
* [[Mediastinum]]
*[[Mediastinum]]
|-
|-
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary vein sarcoma'''
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary vein sarcoma'''
Line 1,159: Line 1,160:
* Mean age of diagnosis is 49
* Mean age of diagnosis is 49
|
|
* [[Smooth muscle]]
*[[Smooth muscle]]
|
|
* [[Pulmonary veins|Pulmonary vein]]
*[[Pulmonary veins|Pulmonary vein]]
|
|
* Fleshy-tan tumor
* Fleshy-tan tumor
Line 1,168: Line 1,169:
* Invasion of wall of the [[vein]]
* Invasion of wall of the [[vein]]
|
|
* [[Smooth muscle]] differentiation
*[[Smooth muscle]] differentiation
* Moderate to highly cellular [[Spindle cells|spindle cell]] [[neoplasms]]  
* Moderate to highly cellular [[Spindle cells|spindle cell]] [[neoplasms]]
* [[Epithelioid]] morphology  
*[[Epithelioid]] morphology
|
|
* [[Vimentin]]
*[[Vimentin]]
* [[Desmin]]
*[[Desmin]]
* [[Actin]]
*[[Actin]]
* [[Keratin]]
*[[Keratin]]
|
|
* N/A
* N/A
|}
|}


=== '''The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.'''<ref name="pmid4353362">{{cite journal |vauthors=Chaudhuri MR |title=Primary pulmonary cavitating carcinomas |journal=Thorax |volume=28 |issue=3 |pages=354–66 |year=1973 |pmid=4353362 |pmc=470041 |doi= |url=}}</ref><ref name="pmid8572761">{{cite journal |vauthors=Mouroux J, Padovani B, Elkaïm D, Richelme H |title=Should cavitated bronchopulmonary cancers be considered a separate entity? |journal=Ann. Thorac. Surg. |volume=61 |issue=2 |pages=530–2 |year=1996 |pmid=8572761 |doi=10.1016/0003-4975(95)00973-6 |url=}}</ref><ref name="pmid10377211">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid103772112">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid22429393">{{cite journal |vauthors=Suri HS, Yi ES, Nowakowski GS, Vassallo R |title=Pulmonary langerhans cell histiocytosis |journal=Orphanet J Rare Dis |volume=7 |issue= |pages=16 |year=2012 |pmid=22429393 |pmc=3342091 |doi=10.1186/1750-1172-7-16 |url=}}</ref> ===
==='''The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.'''<ref name="pmid4353362">{{cite journal |vauthors=Chaudhuri MR |title=Primary pulmonary cavitating carcinomas |journal=Thorax |volume=28 |issue=3 |pages=354–66 |year=1973 |pmid=4353362 |pmc=470041 |doi= |url=}}</ref><ref name="pmid8572761">{{cite journal |vauthors=Mouroux J, Padovani B, Elkaïm D, Richelme H |title=Should cavitated bronchopulmonary cancers be considered a separate entity? |journal=Ann. Thorac. Surg. |volume=61 |issue=2 |pages=530–2 |year=1996 |pmid=8572761 |doi=10.1016/0003-4975(95)00973-6 |url=}}</ref><ref name="pmid10377211">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid103772112">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid22429393">{{cite journal |vauthors=Suri HS, Yi ES, Nowakowski GS, Vassallo R |title=Pulmonary langerhans cell histiocytosis |journal=Orphanet J Rare Dis |volume=7 |issue= |pages=16 |year=2012 |pmid=22429393 |pmc=3342091 |doi=10.1186/1750-1172-7-16 |url=}}</ref>===
{| class="wikitable"
{| class="wikitable"
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease
Line 1,202: Line 1,203:
|-
|-
| style="background:#DCDCDC;" align="center" + |Acute Lung abscess
| style="background:#DCDCDC;" align="center" + |Acute Lung abscess
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|'''-'''
|'''-'''
Line 1,221: Line 1,222:
([[Lung cancer|primary lung cancer]])
([[Lung cancer|primary lung cancer]])
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
| +
| +
|
|
*Coin-shaped lesion  
*Coin-shaped lesion
*Thick wall(>15mm)
*Thick wall(>15mm)
*Ground glass opacities 
*Ground glass opacities 
Line 1,240: Line 1,241:
|-
|-
| style="background:#DCDCDC;" align="center" + |[[Tuberculosis, pulmonary|Pulmonary Tuberculosis]]
| style="background:#DCDCDC;" align="center" + |[[Tuberculosis, pulmonary|Pulmonary Tuberculosis]]
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|
|
*[[Cavitation|Cavitations]] in the upper lobe of the [[lung]]
*[[Cavitation|Cavitations]] in the upper lobe of the [[lung]]
Line 1,257: Line 1,258:
|-
|-
| style="background:#DCDCDC;" align="center" + |[[Pneumonia|Necrotizing Pneumonia]]
| style="background:#DCDCDC;" align="center" + |[[Pneumonia|Necrotizing Pneumonia]]
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|
|
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,276: Line 1,277:
|-
|-
| style="background:#DCDCDC;" align="center" + |Empyema
| style="background:#DCDCDC;" align="center" + |Empyema
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
| +
| +
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,293: Line 1,294:
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,307: Line 1,308:
*Increased [[pulmonary]] markings
*Increased [[pulmonary]] markings
*Honeycombing
*Honeycombing
*[[Atelectasis]]  
*[[Atelectasis]]
|
|
* CT confirms the diagnosis
* CT confirms the diagnosis
Line 1,314: Line 1,315:
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|
|
| +
| +
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|
|
*[[Pulmonary]] [[nodules]]  
*[[Pulmonary]] [[nodules]]
*[[Cavities]]
*[[Cavities]]
*Infiltrates
*Infiltrates
Line 1,331: Line 1,332:
|-
|-
| style="background:#DCDCDC;" align="center" + |[[Sarcoidosis]]
| style="background:#DCDCDC;" align="center" + |[[Sarcoidosis]]
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
| +
| +
|
|
*[[Bilateral]] [[Lymphadenopathy|adenopathy]]
*[[Bilateral]] [[Lymphadenopathy|adenopathy]]
*Coarse reticular opacities  
*Coarse reticular opacities
|
|
*More common in African-american females
*More common in African-american females
Line 1,354: Line 1,355:
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|
|
Line 1,371: Line 1,372:
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
| +
| +
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|
|
Line 1,385: Line 1,386:
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
| +
| +
| +
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 1,395: Line 1,396:
* Patchy [[Consolidation (medicine)|consolidation,]]
* Patchy [[Consolidation (medicine)|consolidation,]]


* Ground-glass opacities  
* Ground-glass opacities


* [[Nodules]]
*[[Nodules]]
|
|
* Biopsy
* Biopsy

Revision as of 21:05, 8 July 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2] , Eiman Ghaffarpasand, M.D. [3],

Overview

Lung cancer must be differentiated from other conditions that cause hemoptysis, cough, dyspnea, wheezing, chest pain, dysphonia, dysphagia, unexplained weight loss, unexplained loss of appetite, and fatigue. These conditions include pneumonia, bronchitis, metastatic cancer from a non-thoracic primary site, infectious granuloma, pulmonary tuberculosis, tracheal tumors, and a thyroid mass.


Differentiating Lung Cancer from Other Diseases

Lung cancer must be differentiated from other cavitary lung lesions. The table below summarizes the differentiation:

Causes of

lung cavities

Differentiating Features Differentiating radiological findings Diagnosis

confirmation

  • CXR and CT demonstrates cavities in the upper lobe of the lung
  • Sputum smear positive for acid-fast bacilli and nucleic acid amplification tests (NAAT) is used on sputum or any sterile fluid for rapid diagnosis and is positive for mycobacteria.
  • Any age group
  • Acute, fulminant life threating complication of prior infection
  • >100.4 °F fever, with hemodynamic instability
  • Worsening pneumonia-like symptoms
  • CBC is positive for causative organism
  • Children and elderly are at risk
  • Empyema appears lenticular in shape and has a thin wall with smooth luminal margins
  • Pulmonary nodules with cavities and infiltrates are a frequent manifestation on CXR
  • Elderly females of 40-50 age group
  • Manifestation of rheumatoid arthritis
  • Presents with other systemic symptoms including symmetric arthritis of the small joints of the hands and feet with morning stiffness are common manifestations
  • Pulmonary nodules with cavitation are located in the upper lobe (Caplan syndrome) on X-ray
  • On CXR bilateral adenopathy and coarse reticular opacities are seen
  • CT of the chest demonstrates extensive hilar and mediastinal adenopathy
  • Additional findings on CT include fibrosis (honeycomb, linear, or associated with bronchial distortion), pleural thickening, and ground-glass opacities.[7]
  • Common appearance on CT is patchy consolidation,often accompanied by ground-glass opacities and nodules.[11]
  • Exclusively afflicts smokers, with a peak age of onset of between 20 and 40 years
  • Clinical presentation varies, but symptoms generally include months of dry cough, fever, night sweats, and weight loss
  • Skin is involved in 80% of the cases, scaly erythematous rash is typical
  • Thin-walled cystic cavities are the usual radiographic manifestation, observed in over 50% of patients by either CXR or CT scans.[13]
  • Biopsy of the lung

The following table summarizes the differentiation of various lung tumors based on histological and topographical features:[14]

Abrevations:

HPV: human papillomavirus; CEA: Carcino embryogenic antigen; TTF1: Thyroid transcription factor-1; EMA: Epithelial membrane antigen; CK: Cyto keratin; CD: Cluster differentiation; NCAM: Neural Cell Differentiation Molecule;

MMP's: Mettaloprotineases matrix ; GFAP: Glial fibrocilliary acid protein

Benign Lung Tumors[15]
Benign lung tumor Risk/Epidemiology Pleuripotent cells Topography Gross Histology Immunohistochemistry Imaging Metastasis
Papilloma[16] Squamous cell papilloma
  • HPV 6 and 11
  • Men
  • Median age of diagnosis is 54 years
  • Endobronchial
  • Cauliflower-like lesions
  • Tan-white soft to semifirm protrutions
  • Loose fibrovascular core
  • Stratified squamous epithelium
  • Acanthosis
  • Binucleate forms and perinuclear halos
  • Koilocytosis
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Glandular papilloma
  • Rare
  • Mean age of diagnosis is 68 years
  • Endobronchial
  • White to tan endobronchial polyps that measure from 0.7-1.5 cm
  • N/A
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Adenoma[17] Alveolar adenoma
  • Mean age of diagnosis is 53 years
  • Female predominance
  • All lung lobes
  • Lower lobes
  • Hilar
  • 0.7-6.0 cm
  • Well demarcated smooth
  • Lobulated, multicystic
  • Soft to firm
  • Pale yellow to tan cut surfaces
  • Well circumscribed
  • Homogenous
  • Non-calcified
  • Solitary mass
  • N/A
Papillary adenoma[18]
  • Mean age of diagnosis is 32 years
  • Male predominance
  • Bronchioloalveolar cell
  • No lobar predilection
  • Involves alveolar parenchyma
  • Well defined
  • Encapsulated
  • Soft, spongy to firm mass
  • Granular gray white/ brown
  • 1.0- 4.0 cm
  • Incidental finding
  • N/A
Mucinous cystadenoma
  • No sex predilection
  • Mean age of diagnosis is 52 years
  • Central
  • White-pink to tan
  • Smooth and shiny tumors
  • Gelatinous mucoid solid core
  • 0.7-7.5 cm
  • Numerous mucin-filled cystic spaces
  • Non-dilated microacini, glands, tubules and papillae
  • Coin lesion
  • Air-meniscus sign
  • N/A
Malignant Lung Tumors[19]
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Squamous cell carcinoma (SCC)[20] Papillary
  • Epithelial cells
  • Central
  • Exophytic
  • Intra-epithelial
  • Without invasion
Clear cell
Basaloid
  • Peripheral palisading of nuclei.
  • Poor differentiation
Small cell carcinoma[21]
  • Bronchial precursor cell
  • Peripheral
  • White-tan, soft, friable perihilar masses
  • Extensive necrosis
  • 5% peripheral coin lesions
  • Sheet-like growth
  • Nesting
  • Trabeculae
  • Peripheral palisading
  • Rosette formation
  • High mitotic rate
  • Bone marrow
  • Liver
Adenocarcinoma[22][23][24] Acinar adenocarcinoma
  • Columnar cells of bronchioles
  • Peripheral
  • Single or multiple lesions
  • Different in size
  • Peripheral distribution
  • Gray-white central fibrosis
  • Pleural puckering
  • Anthracotic pigmentation
  • Lobulated or ill defined edges
  • Irregular-shaped glands
  • Malignant cells:
    • Hyperchromatic nuclei
    • Fibroblastic stroma
  • Peripheral nodules under 4.0 cm in size
  • Central location as a hilar or perihilar mass
  • Rarely show cavitations.
  • Hilar adenopathy
  • Adenocarcinomas account for the majority of small peripheral cancers identified radiologically.
Aerogenous spread is characteristic
  • Brain
  • Bone
  • Adrenal glands
  • Liver
  • Kidney
  • Gastrointestinal Tract
Papillary adenocarcinoma
Bronchio-alveolar carcinoma Non-mucinous
Mucinous
  • Low grade differentiation
  • Composed of:
    • Tall columnar cells
    • Basal nuclei
    • Pale cytoplasm resembling goblet cells
    • Varying amounts of cytoplasmic mucin
  • Cytologic atypia
Mixed non-mucinous and mucinous or indeterminate
  • Mixed type of cells
  • Low to high grade differentiated cells.
Solid adenocarcinoma with mucin production Fetal adenocarcinoma
Mucinous (“colloid”) carcinoma
Mucinous cystadenocarcinoma
Signet ring adenocarcinoma
  • Focal
  • Cells with nuclei displaced to sides
  • Components of other cells are present.
Clear cell adenocarcinoma
  • Clear cells with no nuclei
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Large cell carcinoma[25] Basaloid large cell carcinoma of the lung
  • Approximately 10% of lung cancers
  • Smoking
  • Soft, pink-tan tumor
  • Invasive growth pattern
  • Peripheral palisading
  • Small, monomorphic, cuboidal fusiform
  • Large, peripheral masses
Clear cell carcinoma of the lung
Lymphoepithelioma-like carcinoma of the lung
Large-cell lung carcinoma with rhabdoid phenotype
Mixed type
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Sarcomatoid carcinoma[26] Carcinosarcoma
  • Central or peripheral
  • Upper lobes
  • No specific imaging features 
Spindle cell carcinoma
  • Only spindle shaped tumor cells
  • Lymphoplasmacytic infiltrates
Giant cell carcinoma
Pleomorphic carcinoma
Pulmonary blastoma
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Carcinoid tumor[27] Typical carcinoid

Atypical carcinoid

  • Most common in males
  • Mean age of diagnosis 45
  • Atypical carcinoid is more commonly peripheral
  • Firm, well demarcated, tan to yellow tumors
  • Uniform polygonal cells
  • Nuclear atypia
  • Pleomorphism
  • The most common patterns are the organoid and trabecular
  • Highly vascularized fibrovascular stroma
  • Focal necrosis
Salivary gland tumors[28] Mucoepidermoid carcinoma
  • Most patients presents in the third and fourth decade
  • Constitutes of less than 1% tumor
  • No association with cigarette smoking or other risk factors
  • Primitive cells of tracheobronchial origin
  • Bronchial glands
  • Ranging in size from 0.5-6 cm
  • Soft, polypoid, and pink-tan in colour
  • High-grade lesions are infiltrative
  • Well-circumscribed oval or lobulated mass
  • Calcifications
  • Post-obstructive pneumonic infiltrates
Adenoid cystic carcinoma
  • Constitutes less than 1% of all lung tumors
  • Most commonly seen in fourth and fifth decades of life
  • Primitive cells of tracheobronchial origin
  • Gray-white or tan polypoid lesions
  • Size ranges from 1–4 cm
  • Infiltrative margins
  • Invades other cell layers
  • Heterogeneous cellularity
  • Cribriform pattern
  • Perineural invasion
  • Well circumscribed
  • Nodule
Epithelial-myoepithelial carcinoma
  • Age ranges from 33 to 71 years
  • No association with smoking
  • Endobronchial
  • Solid to gelatinous in texture
  • White to gray in colour
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Preinvasive lesions[29] Squamous carcinoma in situ
  • Most commonly seen in fifth or sixth decades
  • Mostly seen in women
  • Basal cells of squamous epithelium
  • Focal or multi-focal plaque-like greyish lesions
  • Nonspecific erythema
  • Even nodular or polypoid lesions
  • Micropapillomatosis
  • Cauliflower like
  • Mosaic pattern
Atypical adenomatous hyperplasia
  • Multiple grey to yellow foci
  • 1mm to 10mm in size
  • Typically not visualized on radiographs
  • Small non-solid nodules
  • Ground-glass opacity
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
  • Endobronchial
  • Early lesions are:
    • Small, gray-white nodules
    • Resembling ‘miliary bodies’
  • Larger carcinoid tumors are:
    • Firm
    • Homogeneous
    • Well-defined
    • Grey or yellow-white masses
  • Mosaic pattern of air trapping
  • Sometimes with nodules
  • Thickened bronchial and bronchiolar walls
Variants of lung carcinoma Risk Factors/Epidemiology Pleuripotent cell Topography Gross Histology Immunohistochemistry Imaging Metastasis
Mesenchymal tumors[30] Epithelioid haemangioendothelioma / Angiosarcoma
  • Caucasian
  • 80% are women
  • Endothelial cells
  • 0.3-2.0 cm circumscribed mass
  • Gray-white or gray-tan firm tissue
  • Yellow flecks
  • Central calcifications
  • Cut surface has a cartilaginous consistency
Pleuropulmonary blastoma
  • Most common in children
  • Median age of diagnosis is 2 years
  • Purely cystic
  • Thin-walled
  • Rarely solid
  • Firm to gelatinous
  • Upto 15 cm
  • Unilateral
  • Localized airfilled cysts
  • Septal thickening or an intracystic mass
Chondroma
  • Young women
  • Capsulated lobules
  • Hypocellular
  • Features of malignancy are absent
  • N/A
  • Multiple
  • Well circumscribed lesions
  • “Pop-corn” calcifications
Congenital peribronchial myofibroblastic tumor
  • Along the bronchi
  • 5-10 cm
  • Well-circumscribed
  • Non-encapsulated
  • Smooth or multinodular surface
  • The cut surface has a tann-grey to yellow-tan fleshy appearance
  • Hemorrhage
  • Necrosis
  • Well circumscribed
  • Opaque hemithorax
  • Heterogeneous mass
  • Rare
Diffuse pulmonary lymphangiomatosis
  • Children
  • Young adults of both sexes
  • Prominence of the bronchovascular bundles along
  • Anastomosing endothelial-lined cells along lymphatic routes
  • Increased interstitial markings
  • Skin
  • Bone
Inflammatory myofibroblastic tumor
  • Localized to bronchi
  • Solitary
  • Round rubbery masses
  • Yellowish-gray discoloration
  • Average size of 3.0 cm
  • Non-encapculated
  • Calcifications
  • No local invasion
  • Solitary mass
  • Regular borders
  • Spiculated appearance
  • Accompanied by
  • Rare
Pulmonary artery sarcoma
  • Mucoid or gelatinous clots filling vascular lumens
  • The cut surface may show
    • Firm fibrotic areas
    • Bony/gritty or chondromyxoid foci
    • Hemorrhage and necrosis are common in high-grade tumors
  • Spindle cells in
    • A myxoid background
    • Collagenized stroma
    • Recanalized thrombi
Pulmonary vein sarcoma
  • Most common in women
  • Mean age of diagnosis is 49
  • Fleshy-tan tumor
  • Can occlude the lumen of the involved vessel
  • 3.0- 20.0 cm
  • Invasion of wall of the vein
  • N/A

The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.[1][2][4][31][12]

Disease Clinical features

Signs & symptoms

Radiological Findings Characterstic feature
Fever Cough Hemoptysis Dyspnea Chest pain Weight loss Night sweats
High-grade Low grade Productive Dry
Acute Lung abscess + - + - - - + - -
  • Air fluid level
Malignancy

(primary lung cancer)

- + - + + - - + +
  • Coin-shaped lesion
  • Thick wall(>15mm)
  • Ground glass opacities 
Pulmonary Tuberculosis + - + - + - - - +
Necrotizing Pneumonia + - + + - + - -
  • Multiple cavitary lesions
Empyema + - + - + + + - -
Bronchiectasis - - + - + - - - -
  • Linear lucencies
  • Tram tracking appearance
  • Clustered cysts
  • CT confirms the diagnosis
Wegners granulomatosis - - + + + - - -
  • Seen mostly in female age group of 40-55 years
  • Traid of Upper , lower respiratory tract and kidney disease
  • Biopsy of involved organ confirms granulomas
Sarcoidosis + - + - + - - + +
Rheumatoid nodule - - - - - + - + -
Langerhans cell Histiocytosis - - - - - + + + -
  • Thin-walled cystic cavities
Bronchiolitis obliterans - - + - + + + - -
  • Ground-glass opacities
  • Biopsy

References

  1. 1.0 1.1 1.2 Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
  2. 2.0 2.1 Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
  3. Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM (2005). "Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome". Radiology. 237 (1): 342–7. doi:10.1148/radiol.2371041650. PMID 16183941.
  4. 4.0 4.1 4.2 Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
  5. Lee KS, Kim TS, Fujimoto K, Moriya H, Watanabe H, Tateishi U, Ashizawa K, Johkoh T, Kim EA, Kwon OJ (2003). "Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients". Eur Radiol. 13 (1): 43–51. doi:10.1007/s00330-002-1422-2. PMID 12541109.
  6. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R (2001). "Clinical characteristics of patients in a case control study of sarcoidosis". Am. J. Respir. Crit. Care Med. 164 (10 Pt 1): 1885–9. doi:10.1164/ajrccm.164.10.2104046. PMID 11734441.
  7. Brauner MW, Grenier P, Mompoint D, Lenoir S, de Crémoux H (1989). "Pulmonary sarcoidosis: evaluation with high-resolution CT". Radiology. 172 (2): 467–71. doi:10.1148/radiology.172.2.2748828. PMID 2748828.
  8. Murphy J, Schnyder P, Herold C, Flower C (1998). "Bronchiolitis obliterans organising pneumonia simulating bronchial carcinoma". Eur Radiol. 8 (7): 1165–9. doi:10.1007/s003300050527. PMID 9724431.
  9. 9.0 9.1 Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN (2008). "Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review". Ann Thorac Med. 3 (2): 67–75. doi:10.4103/1817-1737.39641. PMC 2700454. PMID 19561910.
  10. Cordier JF, Loire R, Brune J (1989). "Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients". Chest. 96 (5): 999–1004. PMID 2805873.
  11. Lee KS, Kullnig P, Hartman TE, Müller NL (1994). "Cryptogenic organizing pneumonia: CT findings in 43 patients". AJR Am J Roentgenol. 162 (3): 543–6. doi:10.2214/ajr.162.3.8109493. PMID 8109493.
  12. 12.0 12.1 Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.
  13. Moore AD, Godwin JD, Müller NL, Naidich DP, Hammar SP, Buschman DL, Takasugi JE, de Carvalho CR (1989). "Pulmonary histiocytosis X: comparison of radiographic and CT findings". Radiology. 172 (1): 249–54. doi:10.1148/radiology.172.1.2787035. PMID 2787035.
  14. Erasmus JJ, Connolly JE, McAdams HP, Roggli VL (2000). "Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions". Radiographics. 20 (1): 43–58. doi:10.1148/radiographics.20.1.g00ja0343. PMID 10682770.
  15. Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK (June 2012). "Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging". Radiol Oncol. 46 (2): 106–13. doi:10.2478/v10019-012-0021-3. PMC 3472932. PMID 23077446.
  16. Maxwell RJ, Gibbons JR, O'Hara MD (January 1985). "Solitary squamous papilloma of the bronchus". Thorax. 40 (1): 68–71. PMC 459982. PMID 3969658.
  17. Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K (1998). "Solitary bronchioloalveolar adenoma of the lung". Respiration. 65 (6): 483–5. doi:10.1159/000029319. PMID 9817965.
  18. Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D (March 2017). "A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung". Cureus. 9 (3): e1069. doi:10.7759/cureus.1069. PMC 5375953. PMID 28409070.
  19. Kelley LC, Puette M, Langheinrich KA, King B (November 1994). "Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry". Vet. Pathol. 31 (6): 658–62. doi:10.1177/030098589403100605. PMID 7863581.
  20. Roth E, Smidt D (January 1970). "[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs]". Berl. Munch. Tierarztl. Wochenschr. (in German). 83 (1): 7–11. PMID 5528918.
  21. Jackman DM, Johnson BE (2005). "Small-cell lung cancer". Lancet. 366 (9494): 1385–96. doi:10.1016/S0140-6736(05)67569-1. PMID 16226617.
  22. Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson. "Chapter 13, box on morphology of adenocarcinoma". Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. ISBN 1-4160-2973-7.
  23. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S; et al. (2007). "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer". Nature. 448 (7153): 561–6. doi:10.1038/nature05945. PMID 17625570.
  24. Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg
  25. Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G (January 2014). "Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology". Virchows Arch. 464 (1): 61–8. doi:10.1007/s00428-013-1501-6. PMID 24221342.
  26. Huang SY, Shen SJ, Li XY (October 2013). "Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases". World J Surg Oncol. 11: 252. doi:10.1186/1477-7819-11-252. PMC 3850921. PMID 24088577.
  27. Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S (March 2009). "Lung carcinoid tumor biology: treatment and survival". Oncol. Rep. 21 (3): 757–60. PMID 19212636.
  28. Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM (July 2013). "Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome". AJR Am J Roentgenol. 201 (1): W57–63. doi:10.2214/AJR.12.9579. PMC 3767141. PMID 23789697.
  29. Greenberg AK, Yee H, Rom WN (2002). "Preneoplastic lesions of the lung". Respir. Res. 3: 20. PMC 107849. PMID 11980589.
  30. Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP (April 2014). "Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms". Insights Imaging. 5 (2): 237–44. doi:10.1007/s13244-013-0306-0. PMC 3999366. PMID 24407922.
  31. Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.